# FDA Inspection 1135819 - Yamil Canaan, M.D. - February 22, 2021

Source: https://www.globalkeysolutions.net/records/fda_inspections/yamil-canaan-md/b2b97f4c-a3c6-4f7e-a9f9-9e528824d3ef
Source feed: FDA_Inspections

> FDA Inspection 1135819 for Yamil Canaan, M.D. on February 22, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1135819
- Company Name: Yamil Canaan, M.D.
- Inspection Date: 2021-02-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1100868 - 2019-08-22](https://www.globalkeysolutions.net/records/fda_inspections/yamil-canaan-md/212bc83f-e28b-4dc1-b01e-5fa6949b9150)

Company: https://www.globalkeysolutions.net/companies/yamil-canaan-md/dcdb960e-e645-4a03-9161-4ef6a5696ba7

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c